Ciaran Patrick Kelly
#119,383
Most Influential Person Now
Ciaran Patrick Kelly's AcademicInfluence.com Rankings
Ciaran Patrick Kellymedical Degrees
Medical
#1784
World Rank
#2160
Historical Rank
Public Health
#242
World Rank
#251
Historical Rank
Ciaran Patrick Kellyphilosophy Degrees
Philosophy
#5346
World Rank
#8114
Historical Rank
Logic
#2637
World Rank
#3653
Historical Rank
Download Badge
Medical Philosophy
Ciaran Patrick Kelly's Degrees
- Doctorate Medicine University of California, San Francisco
Why Is Ciaran Patrick Kelly Influential?
(Suggest an Edit or Addition)Ciaran Patrick Kelly's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) (2010) (2616)
- ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease (2013) (1460)
- The Oslo definitions for coeliac disease and related terms (2012) (1368)
- Clostridium difficile--more difficult than ever. (2008) (1323)
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). (2018) (1149)
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). (2018) (1083)
- Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. (2000) (999)
- Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. (2002) (947)
- Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea (2001) (824)
- Global Prevalence of Celiac Disease: Systematic Review and Meta‐analysis (2018) (730)
- Body-mass index and symptoms of gastroesophageal reflux in women. (2006) (571)
- Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4 (2012) (544)
- Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. (1997) (425)
- A mouse model of Clostridium difficile-associated disease. (2008) (411)
- Helicobacter pylori moves through mucus by reducing mucin viscoelasticity (2009) (356)
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection (2017) (342)
- Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. (2007) (329)
- Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori. (1999) (298)
- Etiologies and predictors of diagnosis in nonresponsive celiac disease. (2007) (291)
- Can we identify patients at high risk of recurrent Clostridium difficile infection? (2012) (279)
- Intravenous immunoglobulin therapy for severe Clostridium difficile colitis (1997) (277)
- Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. (2005) (272)
- Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI). (2010) (255)
- Underlying Disease Severity as a Major Risk Factor for Nosocomial Clostridium difficile Diarrhea (2002) (254)
- Advances in diagnosis and management of celiac disease. (2015) (249)
- Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. (2009) (242)
- Factors that Influence Adherence to a Gluten-Free Diet in Adults with Celiac Disease (2008) (241)
- A simple validated gluten-free diet adherence survey for adults with celiac disease. (2009) (235)
- Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficileToxin A in Mice (2001) (233)
- Recommendations for probiotic use-2011 update. (2011) (214)
- p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. (2000) (212)
- cag+ Helicobacter pylori Induce Transactivation of the Epidermal Growth Factor Receptor in AGS Gastric Epithelial Cells* (2001) (210)
- Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease (2012) (207)
- Clostridium difficile infection. (1998) (197)
- Diagnosis of celiac sprue (2001) (196)
- Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. (2006) (191)
- Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. (2015) (188)
- The host immune response to Clostridium difficile. (2011) (181)
- Microscopic colitis. (2011) (172)
- Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo‐controlled study (2013) (171)
- P2Y6 Nucleotide Receptor Mediates Monocyte Interleukin-8 Production in Response to UDP or Lipopolysaccharide* (2001) (165)
- Body mass index and the risk of obesity in coeliac disease treated with the gluten‐free diet (2012) (162)
- Patient Perception of Treatment Burden Is High in Celiac Disease Compared With Other Common Conditions (2014) (161)
- A Randomized, Double-Blind Study of Larazotide Acetate to Prevent the Activation of Celiac Disease During Gluten Challenge (2012) (155)
- Clostridium difficile Vaccine and Serum Immunoglobulin G Antibody Response to Toxin A (2003) (151)
- A prospective comparative study of five measures of gluten‐free diet adherence in adults with coeliac disease (2007) (141)
- Saccharomyces boulardii Inhibits ERK1/2 Mitogen-activated Protein Kinase Activation Both in Vitro and in Vivo and Protects against Clostridium difficile Toxin A-induced Enteritis* (2006) (139)
- Clostridium difficile infection in the inflammatory bowel disease patient. (2013) (134)
- Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. (2021) (134)
- Update on Clostridium difficile associated disease (2007) (133)
- Bovine immunoglobulin concentrate-Clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine (1999) (126)
- Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis. (2017) (125)
- Fecal microbiota transplantation--an old therapy comes of age. (2013) (122)
- The Incidence and Clinical Spectrum of Refractory Celiac Disease in a North American Referral Center (2011) (122)
- Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. (2009) (121)
- Signal Transduction Pathways Mediating Neurotensin-stimulated Interleukin-8 Expression in Human Colonocytes* (2001) (115)
- Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells. (1998) (113)
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence (2018) (113)
- Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. (1996) (113)
- Human antibody response to surface layer proteins in Clostridium difficile infection. (2004) (112)
- Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficile. (2008) (110)
- Helicobacter pylori Lipopolysaccharide Binds to CD14 and Stimulates Release of Interleukin-8, Epithelial Neutrophil-Activating Peptide 78, and Monocyte Chemotactic Protein 1 by Human Monocytes (1998) (109)
- Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis. (1997) (99)
- Celiac crisis is a rare but serious complication of celiac disease in adults. (2010) (99)
- Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. (2009) (97)
- Celiac Disease or Non-Celiac Gluten Sensitivity? An Approach to Clinical Differential Diagnosis (2014) (96)
- Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute (2017) (96)
- The incidence and cost of unexpected hospital use after scheduled outpatient endoscopy. (2010) (95)
- IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes. (1997) (94)
- Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice (2012) (93)
- Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice. (2009) (91)
- ZBP-89, Sp1, and Nuclear Factor-κB Regulate Epithelial Neutrophil-activating Peptide-78 Gene Expression in Caco-2 Human Colonic Epithelial Cells* (2001) (91)
- A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. (2009) (90)
- Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers (2002) (89)
- Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice. (2000) (89)
- Prolapsing mucosal polyps: an underrecognized form of colonic polyp—a clinicopathological study of 15 cases (2002) (87)
- Interleukin 8 Secretion from Monocytes of Subjects Heterozygous for the ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutation Is Altered (2004) (87)
- The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice (2012) (86)
- A validated disease-specific symptom index for adults with celiac disease. (2009) (86)
- Monocytic cell necrosis is mediated by potassium depletion and caspase-like proteases. (1999) (85)
- WSES guidelines for management of Clostridium difficile infection in surgical patients (2015) (84)
- No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease. (2017) (80)
- Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity (2017) (79)
- Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management. (2005) (79)
- Donor Screening for Fecal Microbiota Transplantation. (2019) (79)
- In Vitro and In Vivo Antibacterial Evaluation of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections (2013) (79)
- Recurrent Clostridium difficile infection: From colonization to cure. (2015) (78)
- Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers (2016) (75)
- Large intestine. (2010) (75)
- Recurrent Clostridium difficilediarrhoea (2001) (74)
- A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice. (2014) (74)
- Immune response to Clostridium difficile infection. (1996) (74)
- Probiotics in clostridium difficile Infection. (2011) (74)
- Treatment of Helicobacter pylori infection with intra‐gastric violet light phototherapy: A pilot clinical trial (2009) (73)
- Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events. (2008) (71)
- An epidemic of pseudomembranous colitis: importance of person to person spread. (1987) (71)
- Clostridium difficile : Specific Pathogens (2001) (70)
- Factors governing long‐term adherence to a gluten‐free diet in adult patients with coeliac disease (2015) (69)
- Rifalazil Treats and Prevents Relapse of Clostridium difficile-Associated Diarrhea in Hamsters (2004) (68)
- Transcutaneous Immunization with Clostridium difficile Toxoid A Induces Systemic and Mucosal Immune Responses and Toxin A-Neutralizing Antibodies in Mice (2007) (65)
- Mortality in patients with Clostridium difficile infection correlates with host pro-inflammatory and humoral immune responses. (2013) (64)
- Determination of gluten consumption in celiac disease patients on a gluten-free diet. (2018) (63)
- Acid Suppression Therapy Does Not Predispose to Clostridium difficile Infection: The Case of the Potential Bias (2014) (62)
- Interaction between psychiatric and autoimmune disorders in coeliac disease patients in the Northeastern United States (2009) (62)
- Effects of polysaccharopeptide from Trametes Versicolor and amoxicillin on the gut microbiome of healthy volunteers (2014) (61)
- Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay (2018) (60)
- Gastric mucosal α4β7-integrin—positive CD4 T lymphocytes and immune protection against Helicobacter infection in mice (2000) (60)
- Clostridium difficile Carriage and Serum Antitoxin Responses in Children with Inflammatory Bowel Disease (2013) (59)
- Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A. (2008) (59)
- MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice. (2007) (58)
- Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease. (2007) (58)
- The interaction between eating disorders and celiac disease: an exploration of 10 cases (2007) (56)
- P‐Glycoprotein‐170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes (2002) (56)
- Measuring Change In Small Intestinal Histology In Patients With Celiac Disease (2018) (56)
- Prevalence of Abnormal Liver Function Tests in Celiac Disease and the Effect of a Gluten-Free Diet in the US Population (2015) (55)
- IL-8 secretion and neutrophil activation by HT-29 colonic epithelial cells. (1994) (55)
- Probiotic Yeast Inhibits VEGFR Signaling and Angiogenesis in Intestinal Inflammation (2013) (54)
- Update on the immunologic basis of Helicobacter pylori gastritis (2004) (54)
- Comparative Efficacies of Rifaximin and Vancomycin for Treatment of Clostridium difficile-Associated Diarrhea and Prevention of Disease Recurrence in Hamsters (2008) (53)
- TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study. (2021) (50)
- Transactivation of the epidermal growth factor receptor by cag+ Helicobacter pylori induces upregulation of the early growth response gene Egr-1 in gastric epithelial cells (2005) (50)
- Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori. (2002) (49)
- Helicobacter pylori induces up-regulation of the epidermal growth factor receptor in AGS gastric epithelial cells. (2007) (49)
- Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten‐free diet (2017) (48)
- The prospect for vaccines to prevent Clostridium difficile infection. (2015) (47)
- Gliadin-primed CD4+CD45RBlowCD25− T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice (2009) (47)
- Most Patients With Celiac Disease on Gluten-free Diets Consume Measurable Amounts of Gluten. (2019) (45)
- Diagnosis and treatment of gluten-sensitive enteropathy. (1990) (45)
- A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection (2015) (44)
- Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis. (2005) (43)
- Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool (2015) (43)
- Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge (2016) (42)
- Human Monoclonal Antibodies against Clostridium difficile Toxins A and B Inhibit Inflammatory and Histologic Responses to the Toxins in Human Colon and Peripheral Blood Monocytes (2013) (41)
- Clinical Utility of Celiac Disease-Associated HLA Testing (2014) (40)
- Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC (2016) (40)
- Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients (2017) (40)
- Psychological Correlates of Gluten-free Diet Adherence in Adults With Celiac Disease (2009) (39)
- Patients with celiac disease have a lower prevalence of non-insulin-dependent diabetes mellitus and metabolic syndrome. (2013) (38)
- Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis. (2020) (38)
- Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis (2018) (38)
- The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases (2016) (37)
- Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials. (2020) (37)
- Small Intestinal Release Mesalamine for the Treatment of Refractory Celiac Disease Type I (2011) (37)
- Immunoglobulin A deficiency in celiac disease in the United States (2016) (37)
- Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry (2016) (37)
- Clostridium difficile outbreaks: prevention and treatment strategies (2012) (36)
- Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial. (2020) (35)
- Toxin-Mediated Paracellular Transport of Antitoxin Antibodies Facilitates Protection against Clostridium difficile Infection (2014) (34)
- Necrolytic migratory erythema with elevated plasma enteroglucagon in celiac disease. (1989) (33)
- A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection. (2008) (32)
- Novel Nondietary Therapies for Celiac Disease (2019) (32)
- Identification of Toxemia in Patients with Clostridium difficile Infection (2015) (32)
- Multicenter study on season of birth and celiac disease: evidence for a new theoretical model of pathogenesis. (2013) (32)
- Toll-Like Receptor 5-Dependent Immunogenicity and Protective Efficacy of a Recombinant Fusion Protein Vaccine Containing the Nontoxic Domains of Clostridium difficile Toxins A and B and Salmonella enterica Serovar Typhimurium Flagellin in a Mouse Model of Clostridium difficile Disease (2013) (31)
- Nondietary therapies for celiac disease. (2012) (30)
- Gastric mucosal alpha(4)beta(7)-integrin-positive CD4 T lymphocytes and immune protection against helicobacter infection in mice. (2000) (30)
- Clostridium difficile. (2001) (29)
- Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2020) (29)
- Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. (2021) (28)
- Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis (2016) (28)
- Self-reported dietary adherence, disease-specific symptoms, and quality of life are associated with healthcare provider follow-up in celiac disease (2017) (28)
- Esophagitis: a novel adverse event of crizotinib in a patient with ALK-positive non-small-cell lung cancer. (2013) (28)
- Helicobacter pylori Infection Stimulates Plasminogen Activator Inhibitor 1 Production by Gastric Epithelial Cells (2008) (27)
- Exposure sources, amounts and time course of gluten ingestion and excretion in patients with coeliac disease on a gluten‐free diet (2020) (25)
- Natural Clostridioides difficile toxin immunization in colonized infants. (2019) (25)
- The Monoclonal Antitoxin Antibodies (Actoxumab–Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Clostridium difficile Infection (2016) (25)
- Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea. (2019) (24)
- Macrophage-Inflammatory Protein-3α Mediates Epidermal Growth Factor Receptor Transactivation and ERK1/2 MAPK Signaling in Caco-2 Colonic Epithelial Cells via Metalloproteinase-Dependent Release of Amphiregulin1 (2007) (24)
- Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters. (2016) (24)
- M2048 Safety, Tolerability and Effects On Intestinal Permeability of Larazotide Acetate in Celiac Disease: Results of a Phase IIB 6-Week Gluten-Challenge Clinical Trial (2009) (23)
- Meta-Analysis of the Placebo Response in Ulcerative Colitis (2008) (23)
- Symptoms of Functional Intestinal Disorders Are Common in Patients with Celiac Disease Following Transition to a Gluten-Free Diet (2017) (23)
- Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality (2017) (23)
- Current strategies for management of initial Clostridium difficile infection. (2012) (22)
- A Novel Patient-Derived Conceptual Model of the Impact of Celiac Disease in Adults: Implications for Patient-Reported Outcome and Health-Related Quality-of-Life Instrument Development. (2017) (22)
- Multicenter study on the value of ICD-9-CM codes for case identification of celiac disease. (2013) (22)
- Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers. (2022) (22)
- MBX-500, a Hybrid Antibiotic with In Vitro and In Vivo Efficacy against Toxigenic Clostridium difficile (2012) (22)
- Current Concepts Clostridium difficile — More Difficult Than Ever (2008) (21)
- Celiac Disease: Diagnostic Standards and Dilemmas (2015) (21)
- Complement activation within the coeliac small intestine is localised to Brunner's glands. (1989) (21)
- Mucosal and systemic IgA anti-gliadin antibody in celiac disease (1991) (21)
- Heterozygous FZ alpha 1 antitrypsin deficiency associated with severe emphysema and hepatic disease: case report and family study. (1989) (21)
- Diagnostic Accuracy of Point of Care Tests for Diagnosing Celiac Disease (2019) (20)
- Current Status of Celiac Disease Drug Development (2016) (20)
- The association between socioeconomic status and the symptoms at diagnosis of celiac disease: a retrospective cohort study (2016) (20)
- Pathogenicity of Clostridium difficile Toxins (2003) (19)
- Fidaxomicin Inhibits Clostridium difficile Toxin A-Mediated Enteritis in the Mouse Ileum (2014) (19)
- Socioeconomic Risk Factors for Celiac Disease Burden and Symptoms (2016) (18)
- Update on the evaluation and diagnosis of celiac disease (2006) (18)
- Nondietary Therapies for Celiac Disease. (2019) (18)
- Active and Secretory IgA-Coated Bacterial Fractions Elucidate Dysbiosis in Clostridium difficile Infection (2016) (17)
- Monitoring non-responsive patients with celiac disease. (2006) (17)
- New Drugs and Strategies for Management of Clostridium difficile Colitis (2014) (17)
- Clostridium difficile Infection Among Veterans Health Administration Patients (2015) (17)
- Quantifying Gastric Helicobacter pylori Infection: A Comparison of Quantitative Culture, Urease Breath Testing, and Histology (2007) (17)
- Proton pump inhibitors and risk of Clostridium difficile infection: association or causation? (2018) (17)
- Fecal Mycobiota Combined with Host Immune Factors Distinguish Clostridioides difficile Infection from Asymptomatic Carriage. (2021) (16)
- Refractory celiac disease (2007) (16)
- Bezlotoxumab Alone and With Actoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients on Standard of Care Antibiotics: Integrated Results of 2 Phase 3 Studies (MODIFY I and MODIFY II) (2015) (16)
- Celiac Disease (2019) (16)
- Munchausen Syndrome by Proxy: A Narrative Approach to Explanation (1996) (15)
- Antibiotic-Associated Diarrhea, Pseudomembranous Enterocolitis, and Clostridium difficile-Associated Diarrhea and Colitis (2010) (15)
- Celiac Disease and Refractory Celiac Disease (2010) (15)
- Gastric acid-suppressive agents and risk of Clostridium difficile-associated disease. (2006) (15)
- Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease (2021) (15)
- Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection. (2020) (14)
- Prospects for a Vaccine for Clostridium difficile (1998) (14)
- Saccharomyces boulardii CNCM I-745 Modulates the Fecal Bile Acids Metabolism During Antimicrobial Therapy in Healthy Volunteers (2019) (14)
- A multicenter, retrospective, case‐cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients (2017) (14)
- ATOPY AND CHILDHOOD COELIAC DISEASE (1987) (14)
- Navigating the Gluten-free Diet in College (2012) (14)
- Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients (2016) (14)
- Laxative use does not preclude diagnosis or reduce disease severity in Clostridiodes difficile infection. (2019) (14)
- Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-κB Activity (2017) (13)
- ZBP-89 , Sp 1 , and Nuclear Factor-B Regulate Epithelial Neutrophil-activating Peptide-78 Gene Expression in Caco-2 Human Colonic Epithelial Cells * (2001) (13)
- TPL2 Is a Key Regulator of Intestinal Inflammation in Clostridium difficile Infection (2018) (12)
- Bezlotoxumab for Clostridium difficile Infection Complicating Inflammatory Bowel Disease. (2018) (12)
- The cost of a loaf of bread in symptomless celiac disease. (2014) (11)
- Macrophage-Inflammatory Protein-3 Mediates Epidermal Growth Factor Receptor Transactivation and ERK1/2 MAPK Signaling in Caco-2 Colonic Epithelial Cells via Metalloproteinase-Dependent Release of Amphiregulin (2007) (11)
- Open conformation tissue transglutaminase testing for celiac dietary assessment. (2012) (11)
- Fasting breath hydrogen, small intestinal bacterial overgrowth and intestinal transit in coeliac disease (1991) (11)
- Open mini-incision parathyroidectomy for solitary parathyroid adenoma (2014) (10)
- The impact of PCR on Clostridium difficile detection and clinical outcomes. (2015) (10)
- Differential Immunodetection of Toxin B from Highly Virulent Clostridium difficile BI/NAP-1/027 (2015) (10)
- Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection (2017) (10)
- Celiac disease and gastroesophageal reflux disease: yet another presentation for a clinical chameleon. (2011) (9)
- Enteric-Release Budesonide May Be Useful in the Management of Non-Responsive Celiac Disease (2020) (9)
- PATHOGENESIS OF HELICOBACTER PYLORI INFECTION (1998) (9)
- Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection (2020) (9)
- Salivary proline‐rich proteins and gluten: Do structural similarities suggest a role in celiac disease? (2015) (8)
- Leukocyte adhesion in gastrointestinal inflammation (1993) (8)
- 929b Larazotide Acetate, a First In-Class, Novel Tight Junction Regulator, Meets Primary Endpoint and Significantly Reduces Signs and Symptoms of Celiac Disease in Patients on a Gluten-Free Diet: Results of a Multicenter, Randomized, Placebo Controlled Trial (2014) (8)
- Efficacy of Enteric-Release Oral Budesonide in Treatment of Acute Reactions to Gluten in Patients With Celiac Disease. (2020) (8)
- Novel therapeutic approaches for celiac disease. (2014) (8)
- Monocytic cell necrosis is mediated by potassium depletion and caspase-like proteases. (1999) (7)
- Effectiveness and safety of fecal microbiota transplantation for Clostridioides difficile infection: Results from a 5,344 patient cohort study. (2022) (7)
- The vermiform appendix and recurrent Clostridium difficile infection: a curious connection. (2011) (7)
- Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease. (2015) (7)
- Inter- and Intra-assay Variation in the Diagnostic Performance of Assays for Anti-tissue Transglutaminase in 2 Populations. (2019) (7)
- Ultrasensitive and quantitative toxin measurement correlates with baseline severity, severe outcomes, and recurrence among hospitalized patients with Clostridioides difficile infection. (2021) (7)
- 599 The Monoclonal Antibody, Bezlotoxumab Targeting C. difficile Toxin B Shows Efficacy in Preventing Recurrent C. difficile Infection (CDI) in Patients at High Risk of Recurrence or of CDI-Related Adverse Outcomes (2016) (7)
- American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. (2022) (7)
- Celiac Disease: Fallacies and Facts. (2021) (6)
- HOSPITAL OUTBREAKS OF CLOSTRIDIUM DIFFICILE (1986) (6)
- Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll Like Receptor 9 Signaling. (2020) (6)
- Recent developments in the management of recurrent Clostridioides difficile infection. (2020) (6)
- The Potential for Treatment of Potential Celiac Disease. (2016) (6)
- Prevalence of celiac disease in China: Meta‐analysis and serological survey in high‐risk populations (2021) (6)
- Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection (2021) (6)
- Meta-analysis of randomised controlled trials (1997) (6)
- High anti-toxin a antibody levels are associated with protection against recurrent clostridium difficile diarrhea (2000) (6)
- Chapter Fifty-One – Treatment of Clostridium difficile diarrhea and colitis (2006) (6)
- 188 Lactic Acid Mediates Anti-Cancer Function of Probiotic Yeast (2012) (5)
- Novel Chimeric Protein Vaccines Against Clostridium difficile Infection (2018) (5)
- Gastrointestinal cancer in celiac disease: "the first days are the hardest days, don't you worry anymore?". (2012) (5)
- IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes. (1997) (5)
- Toxin A-predominant Pathogenic C. difficile: A Novel Clinical Phenotype. (2020) (5)
- Transactivation of the EGFR by cag+ Helicobacter pylori induces upregulation of the early growth response gene Egr-1 in gastric epithelial cells (2005) (4)
- 585 A Randomized, Double-Blind Study of AT-1001 for the Prevention of Celiac Disease Activation with Gluten Challenge (2008) (4)
- Is duodenal biopsy required in all patients with suspected celiac disease? (2008) (4)
- Treatment of antibiotic-associated diarrhea caused by Clostridium difficile (2010) (4)
- Socioeconomic Status Influences Celiac Disease Diagnosis (2011) (4)
- Use of oxygen driven nebulizer delivery systems for beta —2 agonists in chronic bronchitis (1985) (4)
- Small cell and squamous cell lung carcinomas: sequential occurrence at a single site. (1987) (4)
- Gastroesophageal reflux disease (GERD) and asthma in women (2003) (4)
- Studies on the interaction between alpha-gliadin and HLA and T cell receptor molecules in coeliac disease. (1988) (4)
- 70 Serum I-Fabp Is a Useful Tool for Evaluation of Gluten Challenge in Adults With Celiac Disease (2013) (4)
- MIP-3 (cid:1) neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice (2007) (4)
- Reply to Fabre et al. (2018) (3)
- Characteristics and Outcomes in Patients with C. Difficile Infection (CDI) and Inflammatory Bowel Disease: Bezlotoxumab Versus Placebo (2017) (3)
- PSEUDOMEMBRANOUS COLITIS AND CEFOTAXIME (1986) (3)
- Infections: In Vitro and in Vivo Antibacterial Evaluation (2013) (3)
- Detection of mixed-strain infections by FACS and ultra-low input genome sequencing (2018) (3)
- Current pharmacological strategies in Alzheimer's disease (1995) (3)
- Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection (2011) (3)
- Su1447 Ex Vivo Gluten Challenge Differentiates Patients With Celiac Disease on a Gluten Free Diet From Healthy Individuals (2014) (3)
- BASIC—ALIMENTARY TRACT A Mouse Model of Clostridium difficile-Associated Disease (2008) (3)
- Anemia Etiology and the Response to a Gluten-Free Diet in Untreated Patients With Celiac Disease: A 2-Year Follow-Up (2022) (3)
- Playing host to the difficult Clostridium. (2007) (3)
- Factitious Disorder By Proxy: The Role of Child Mental Health Professionals (1997) (3)
- Efficacy of bezlotoxumab in patients receiving metronidazole, vancomycin, or fidaxomicin for treatment of Clostridium difficile infection (CDI) (2016) (3)
- Psychological Correlates of Gluten-Free Diet Adherence in Adults with Celiac Disease: 226 (2007) (2)
- Absence of Toxemia in Clostridioides difficile Infection: Results from Ultrasensitive Toxin Assay of Serum (2020) (2)
- Coeliac disease: Missing villi? The search for coeliac disease in the Asia–Pacific region (2014) (2)
- Rifaximin Chaser Following Standard Therapeutic Cocktail for Breaking the Cycle of Multiple C. difficile Diarrhea Recurrences: 521 (2006) (2)
- 394 Celiac Disease Has Higher Treatment Burden Than Common Medical Conditions (2012) (2)
- Rat Intestinal Epithelial Cells ProductionMacrophage-Inflammatory Protein-2 Toxin A Stimulates Clostridium difficile (1998) (2)
- Proton Pump Inhibitors and the Risk for Clostridium difficile Infection—Reply (2009) (2)
- Commentary: larazotide acetate ‐ an exciting new development for coeliac patients? Authors’ reply (2013) (2)
- Intravenous immunoglobulin therapy for severe Clostridium di Y cile colitis (1998) (2)
- Nasal collumella schwannoma in a child (2011) (2)
- 630 TAK-101 (TIMP-GLIA) PREVENTS GLUTEN CHALLENGE INDUCED IMMUNE ACTIVATION IN ADULTS WITH CELIAC DISEASE (2020) (2)
- Understanding celiac disease monitoring patterns and outcomes after diagnosis: A multinational, retrospective chart review study (2021) (2)
- Stool interleukin-1β differentiates Clostridioides difficile infection from asymptomatic carriage and non-C.difficile infection diarrhea. (2022) (2)
- Changes in Body Mass Index on the Gluten Free Diet: Risk of Obesity (2011) (2)
- Identification of Lactic Acid From Probiotic Yeast as an Anti‐Cancer and Anti‐Inflammatory Component: P‐188 YI (2012) (2)
- Non-responsive celiac disease in children on a gluten free diet (2021) (2)
- IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed monocytes (1995) (2)
- A Computational Method to Dissect Colonization Resistance of the Gut Microbiota against Pathogens (2022) (1)
- Humoral Immune Response to Clostridioides difficile Toxins A and B in Hospitalized Immunocompromised Patients With C difficile Infection (2021) (1)
- Antibodies to Clostridium difficile Toxins in Inflammatory Bowel Disease Patients: 1534 (2012) (1)
- Serum IgA in Celiac Disease: The Unrecognized Importance of Partial IgA Deficiency (2011) (1)
- FDA Draft Guidance for Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet: Comments by the Society for the Study of Celiac Disease. (2022) (1)
- Salivary Gluten Degradation and Oral Microbial Profiles in Health and Celiac Disease 1 (2017) (1)
- Cell death and clostridium difficile toxins: the murder weapon uncovered. (1997) (1)
- Sa1286 Refractory Collagenous Sprue Responsive to Salvage Therapy With Infliximab (2013) (1)
- Suloctidil hepatitis: A case presentation (1987) (1)
- Clostridium Difficile Toxin A‐associated DNA Augments the Host Inflammatory Response: P‐258 YI (2012) (1)
- Etiologies and Predictors of Diagnosis in Non-Responsive Celiac Disease: 276 (2006) (1)
- Sa1258 Risk of Cardiovascular Disease in Individuals With Celiac Disease (2013) (1)
- Effect of endogenous Clostridium difficile toxin antibodies on recurrence of C. difficile infection (2020) (1)
- A Validated Gluten Free Diet Adherence Survey for Adults with Celiac Disease: 271 (2008) (1)
- Reflux, dyspepsia, and disorders of the foregut. (2007) (1)
- M2025 A Validated Disease Specific Symptom Index for Adults with Celiac Disease (2009) (1)
- Response to Aziz et al. (2014) (1)
- Sa1271 A Clinical Predictive Model for Differentiation of Celiac Disease and Non-Celiac Gluten Sensitivity (2013) (1)
- H. Pylori produces a soluble factor which inhibits ENA-78 chemokine production by AGS gastric epithelial cells (1998) (1)
- Differential α4β7-integrin and L-selectin homing receptor expression during natural and vaccine-induced immune responses to Helicobacter infection in mice (1998) (1)
- S1224 Variability of Anti-C. difficile Toxin Antibody Titers in Commercially-Available IVIG Preparations May Impact Treatment Efficacy (2010) (1)
- The Clinical Utility of HLA Testing in Celiac Disease Differential Diagnosis (2011) (1)
- Low testosterone in non-responsive coeliac disease: A case series, case-control study with comparisons to the National Health and Nutrition Examination Survey. (2016) (1)
- Tu1470 INCREASED RISK OF CELIAC DISEASE IN SOUTHERN CHINA (2020) (1)
- Clostridium difficile toxin-induced IL-8 release by monocytes follows tyrosine kinase, NF-kB and NF-IL6 activation (1998) (1)
- Proton Pump Inhibitors and the Risk for Clostridium difficile Infection. Author's reply (2009) (1)
- Helicobacter pylori stimulates chemotactic cytokine release from human monocytes (1995) (1)
- Not All That Flattens is Celiac Disease: Mimics of Celiac Enteropathy in Contemporary Clinical Practice (2011) (1)
- Helicobacter pylori activates Akt via transactivation of the EGF receptor in AGS gastric epithelial cells (2003) (1)
- Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort (2022) (1)
- Low dose E. coli enterotoxin for urease-based oral immunization against H. pylori in healthy volunteers: Can it be safe and effective (2000) (1)
- Reply to Schreier and Libow (1998) (1)
- Saccharomyces Boulardii Inhibits VEGFR Signaling and Angiogenesis in Intestinal Inflammation (2011) (1)
- Irish Society of Gastroenterology — Winter Meeting Held at Freeman Auditorium, Mater Misericordiae Hospital, Dublin on Friday, 20th and Saturday, 21st November, 1987 (1988) (0)
- Red Flags in the Diagnosis Irritable Bowel Syndrome: Is Proper Documentation Taking Place? (2006) (0)
- Correction for Zhang et al., Toxin-Mediated Paracellular Transport of Antitoxin Antibodies Facilitates Protection against Clostridium difficile Infection (2015) (0)
- ACELL Mar. 45/3 (1999) (0)
- 40. Celiac Disease (2012) (0)
- Accurate Diagnosis of Clostridioides difficile Infection (2020) (0)
- Book Review The Growth of Gastroenterologic Knowledge during the Twentieth Century Edited by Joseph B. Kirsner. 522 pp., illustrated. Philadelphia, Lea and Febiger, 1994. $75. 0-8121-159209 (1994) (0)
- Steroid Therapy Exacerbates Clostridium difficile Infection in a Mouse Model: 1820 (2013) (0)
- Sa1269 Serum Anti-Gal Levels in Celiac Disease Patients (2013) (0)
- 847 Evaluation of Antibodies to Cytolethal Distending Toxin B (CdtB) and Vinculin in Celiac Disease (2015) (0)
- Tu1006 THE ASSOCIATION BETWEEN INFLAMMATORY BOWEL DISEASE AND CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS (2020) (0)
- Microparticles Are Novel Biomarkers in Predicting Celiac Disease Activity: 324 (2012) (0)
- National scientific medical meeting 1997 abstracts (1998) (0)
- AP-2 and NF-κB regulate ENA-78 gene expression in Salmonella dublin infected Caco-2 intestinal epithelial cells (1998) (0)
- 883. Stool Toxin Concentrations Are Higher in Children with Baseline Severe Disease, Severe Outcomes, and Recurrence (2022) (0)
- Fidaxomicin and OP1118 Inhibit C. Difficile Toxin A- and Bmediated Inflammatory Responses via Inhibition of NF-KB Activity (2017) (0)
- Protease-activated receptor 2 in the intestinal inflammatory response induced by Clostridium difficile toxin A. (2007) (0)
- Mo1852 The Impact of Polymerase Chain Reaction on Clostridium difficile Detection and Clinical Outcomes (2015) (0)
- Redefining Clostridioides difficile infection antibiotic response and clinical outcomes. (2023) (0)
- W1275 Failure of Metronidazole Therapy for C. difficile-Associated Disease (Cdad): Risk Factors and Historical Trends (2008) (0)
- Delayed Radionucleotide Gastric Emptying Studies Predict Morbidity in Diabetics with Symptoms of Gastroparesis: 1023 (2008) (0)
- Impact of Helicobacter Pylori on Mucus Rheology (2006) (0)
- Frequency of Anemia at Diagnosis of New and Non-Responsive Celiac Disease: A Comparison With the U.S. National Population (2018) (0)
- 619 - Determination of Gluten Grams Ingested and Excrected by Adults Eating Gluten-Free (Doggiebag) (2018) (0)
- Royal Academy of Medicine in Ireland (1985) (0)
- 94 Probiotic Saccharomyces boulardii CNCM I-745 Inhibits Hypervirulent Clostridium difficile-Associated Cecal Tissue Damage and Pro-Inflammatory Cytokine Expression in Hamsters (2016) (0)
- Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool (2015) (0)
- Reply to Ito. (2022) (0)
- Prevalence of Celiac Disease : Systematic Review and Meta-analysis (2017) (0)
- Antibiotic-Associated Microbiome Changes in Healthy Volunteers and Corrective Impact of the Probiotic Saccharomyces boulardii: Presidential Poster: 685 (2014) (0)
- Pseudomembranous colitis and Clostridium difficile infection (2003) (0)
- Patchiness of Intestinal Mucosal Damage in Patients following a Gluten-Free Diet (2017) (0)
- Book Reviews (1996) (0)
- Mo1227 Cathelicidin Mimic Ceragenin CSA13 Modulates Clostridium difficile Associated Colitis and Toxin a Mediated Enteritis in Mice (2015) (0)
- W1786 A Novel Experimental Mouse Model of Clostridium difficile Associated Disease (2008) (0)
- Mo1043 - Determination of Gluten Consumption by Celiac Disease Patients on a Gluten-Free Diet (2018) (0)
- A108 PROBIOTICS FOR CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2020) (0)
- 1107 The Anti-Microbial Peptide Cathelicidin Modulates Clostridium difficile Toxin a - Mediated Inflammatory Responses in Mouse Intestine and Human Primary Monocytes (2012) (0)
- Su1135 – Prevalence, Causes and Characteristics of Nonresponsive Celiac Disease (2017) (0)
- Small Bowel Findings in Wireless Capsule Endoscopy (2009) (0)
- S2029 Celiac Crisis in Adults: Rare or Just Rarely Recognized (2010) (0)
- Differences in mRNA stability determine the kinetics of ENA-78 and IL-8 protein production by Caco-2 cells (2000) (0)
- W1277 Recurrences of Clostridium difficile Associated Diarrhea- SAME Strain or Different Strain? (2008) (0)
- Etiologies and Clinical Features of Nonresponsive Celiac Disease in Children Under the Age of 18 Years: ACG Fellows-In-Training Award: 2429 (2015) (0)
- Toll-Like Receptor 5-Dependent Immunogenicity and Protective Efficacy of a Recombinant Fusion Protein Vaccine Containing the Nontoxic Domains of Clostridium difficile Toxins A and B and Salmonella enterica Serovar Typhimurium Flagellin in a Mouse Model of Clostridium difficile Disease (2013) (0)
- M2050 Nutritional Intake of Adults with Celiac Disease in the U.S.: Are They Meeting Their Needs? (2009) (0)
- A Prospective Study of Factors Associated with Increased Gluten-Free Diet Adherence in Adults with Celiac Disease: 227 (2007) (0)
- Baseline stool toxin concentration is associated with risk of recurrence in children with Clostridioides difficile infection. (2023) (0)
- 832 Clostridium difficile Carriage and Serum Antibody Responses in Pediatric Outpatients With Inflammatory Bowel Disease (2013) (0)
- Celiac Disease Is Protective Against Cardiovascular Risk Factors: 317 (2012) (0)
- Cathelicidin Modulates Clostridium difficile Toxin a-Mediated Enteritis (2011) (0)
- Comparative Efficacies of Rifaximin and Vancomycin for Treatment of Clostridium difficile -Associated Diarrhea and Prevention of Disease Recurrence in Hamsters (cid:1) (2008) (0)
- Larazotide Acetate (AT-1001) Prevents Immunologic Changes Induced by Gluten Challenge in Patients with Celiac Disease: 298 (2008) (0)
- ACE Inhibitors and ARBs Do Not Improve Outcomes in Patients with Clostridium difficile Infection: 483 (2009) (0)
- Antibiotic-Associated Diarrhea and Clostridioides difficile Infection (2020) (0)
- 428 – Solute Carrier Family 26 Member 3 (SLC26A3) Restoration and Interleukin-1 Beta Inhibition Mediate the Therapeutic Effects of Macrophage Inflammatory Protein 1 Alpha (MIP-1Α/CCL3) Neutralizing Antibody in C. Difficile Infection in Mice (2019) (0)
- AJG-21-1788 1684..1692 (0)
- Royal academy of medicine in ireland (1989) (0)
- Su1029 Socioeconomic Risk Factors for Celiac Disease Burden and Symptoms (2012) (0)
- Sa1293 Serum Cytokine Profiles in Patients With C. difficile Associated-Diarrhea and Non-C. difficile Antibiotic Associated Diarrhea (2014) (0)
- Colitis Clostridium difficile New Drugs and Strategies for Management of (2014) (0)
- Expression of LIX, an enterocyte-expressed CXC chemokine, is increased in DSS-treated mice (2003) (0)
- Higher in vivo fecal concentrations of Clostridioides difficile toxins A and B in patients with NAP-1/027 strain infection. (2022) (0)
- Correction to: Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2021) (0)
- Uridine 5′-diphosphate (UDP) activates IL-3 gene expression in human monocytic cells (2001) (0)
- Interaction Between Psychiatric and Autoimmune Disorders in Celiac Disease Patients in the United States: 260 (2008) (0)
- Early intracellular signalling of Clostridium difficile toxin a (TXA) in rat ileum involves a protein tyrosine kinase-dependent pathway (1998) (0)
- Irish society of gastroenterology (1991) (0)
- 999 Prevalence and Clinical Risk Factors of Nonresponsive Celiac Disease in Children (2016) (0)
- Sa1314 Histologic and Serologic Kinetics in Adults With Celiac Disease Undergoing Gluten Challenge (2012) (0)
- Comparison of Celiac Disease Seen at a Community GI Practice and a Tertiary Center: 272 (2009) (0)
- Bottom of the sole (2011) (0)
- Endogenous Serum IgG Antibodies to Clostridium difficile Toxin B Are Associated with Protection against C. difficile Infection Recurrence (2017) (0)
- Campylobacter enteritis in a pregnant woman with hypogammaglobulinaemia. (1989) (0)
- Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age. (2022) (0)
- H. pylori activates the EGF receptor to regulate IL-8 gene expression in AGS gastric epithelial cells (2001) (0)
- The Combination of Serum I-Fabp and Specific Serology are Highly Predictive Non-Invasive Diagnostic Tools for Celiac Disease in High Pre-Test Populations (2017) (0)
- 221. Assessment and Proposed Revision of Clinical Trial Clostridioides difficile Infection Clinical Response and Outcomes Definitions (2022) (0)
- Response to Dr. Tursi et al. (2002) (0)
- Aspects of large intestinal health and disease. (2013) (0)
- Clinical Spectrum of Refractory Celiac Disease: 273 (2009) (0)
- VESGEN Mapping of Bioactive Protection against Intestinal Inflammation: Application to Human Spaceflight and ISS Experiments (2011) (0)
- A Computational Framework to Quantify Host-Microbiome Interactions in Clostridioides Difficile Infection (2020) (0)
- Su1031 Factors Affecting the Treatment Burden of Celiac Disease (2012) (0)
- Editorial introductions. (2019) (0)
- Small Intestinal Release Mesalamine for Treatment of Refractory Celiac Disease: 284 (2009) (0)
- Efficacy of rifaximin vs. vancomycin for treatment of Clostridium difficile-associated 1 diarrhea and prevention of disease recurrence in hamsters 2 Rifaximin for Clostridium difficile-associated diarrhea 3 4 (2008) (0)
- Mo1667 The Effects of Dietary Protein and Serum-Derived Bovine Immunoglobulin/Protein Isolate in a Murine Model of Clostridium difficile Infection (2016) (0)
- Zinc-requiring nuclear factors of 105 kDa regulate basal ENA-78 gene expression in Caco-2 colonic epithelial cells (2000) (0)
- Book Reviews (1998) (0)
- Sa1753 Fidaxomicin and Opt-1118 Inhibit Clostridium difficile Toxin A - Mediated Inflammation in Mouse Ileum (2013) (0)
- Toward optimal health: Stefano Guandalini [corrected] M.D., and Ciaran P. Kelly, M.D. Discuss celiac disease. Interview by Jodi R Godfrey. (2005) (0)
- Nuclear Factor-B in the Liver: Friend or Foe? (2007) (0)
- W1278 Clostridium difficile NaP-1 Strain Is Not Associated with Severe Disease in a Non-Epidemic Setting (2008) (0)
- P-glycoprotein (Pgp-170) inhmition reduces cortisol and cyclosporin efflux from mdr expressing human T-lymphocytes (2000) (0)
- Mo1279 Low Testosterone Is a Potential Cause of Persistent Symptoms in Males With Celiac Disease: A Case Series and a Case Control Study With Comparisons to National Health and Nutrition Examination Survey (NHANES) (2016) (0)
- Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis (2018) (0)
- Probiotic Yeast Inhibits VEGFR Signaling and Angiogenesis in Colonic Inflammation: P-218. (2011) (0)
- 645. Absence of Toxemia in Clostridioides difficile infection: Results from Ultrasensitive Toxin Assay of Serum (2020) (0)
- A Prospective Study of Five Measures of Gluten Free Diet Adherence in Adults with Celiac Disease: 228 (2007) (0)
- 976. Clostridium difficile Colonization Molecular Epidemiology and Anti-toxin Serological Responses in Healthy Infants: A Prospective Cohort Study (2018) (0)
- A New Model to Predict Survival in Patients with Refractory Celiac Disease (MRCD): Results from a Multinational Study: 1469 (2012) (0)
- Conversion disorder, sexual abuse and interprofessional communication – some lessons to be re-learned (1994) (0)
- 1655Lack of Adherence to SHEA-IDSA Treatment Guidelines for Severe Clostridium difficile Infection is Associated with Increased Mortality (2014) (0)
- Distinct molecular mechanisms regulate the differential expression of the chemokines ENA-78 and IL-8 in Caco-2 cells (1998) (0)
- In Vitro and In Vivo Antibacterial Evaluation of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections (2014) (0)
- Causes and Outcomes of Non-responsive Celiac Disease: 1050 (2016) (0)
- M2026 Small Intestinal Release Mesalamine for Treatment of Refractory Celiac Disease (2009) (0)
- On and Off: A Dual Role for Cysteine Protease Autoprocessing of C difficile Toxin B on Cytotoxicity vs Proinflammatory Toxin Actions? (2018) (0)
- Integrating Gut Microbiota and Host Immune Markers for Highly Accurate Diagnosis of Clostridioides difficile Infection (2020) (0)
- Large intestine. (2011) (0)
- Sa1304 Bone Mineral Density in Celiac Disease (2015) (0)
- Sa1397 Regulators of IgE-Dependent Immune Response Are Activated in the Duodenal Mucosa of Atopic But Not Non-Celiac Gluten Sensitivity (NCGS) Patients (2016) (0)
- Factors Associated with Villus Atrophy in Symptomatic Celiac Disease Patients on a Gluten-Free Diet (2017) (0)
- Sa1298 Perceived Wellbeing in Celiac Disease; Association With Patient Reported Outcomes, Clinical Indices and Biologic Parameters (2015) (0)
- Tu1938 PROBIOTICS FOR CELIAC DISEASE: A SYSTEMATIC REVIEW AND METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2020) (0)
- Tu1382 Correlation of Celiac Serologies and Intestinal Fatty Acid-Binding Protein with Marsh Score and Quantitative Histology (2016) (0)
- Su1432 Prevalence of Celiac Disease Is Higher Among Women With Infertility (2014) (0)
- Transbronchial lung biopsy via flexible fibreoptic bronchoscopy: review of 108 cases. (1985) (0)
- Pancreatic enzyme supplementation versus placebo for improvement of gastrointestinal symptoms in non-responsive celiac disease: A cross-over randomized controlled trial (2023) (0)
- ⁎⁎3723 Quality of life and symptomatic improvement in patients with achalasia: a prospective study. (2000) (0)
- Sa1292 Elevated Serum IL-27 Concentrations Predict Adverse Outcomes in Clostridium difficile Associated Diarrhea (2014) (0)
- Immunology andClostridium difficile (2013) (0)
- 136 Human Monoclonal Antibodies Against Clostridium difficile Toxin a and B Inhibit Inflammatory Responses and Epithelial Cell Damage to Toxins a and B in Human Peripheral Blood Monocytes and Human Colonic Tissues (2013) (0)
- Helicobacter pylori eradication rates and symptoms in patients with endoscopically diagnosed peptic ulcers (2000) (0)
- Strategies to recover otc success (1998) (0)
- AGA abstracts T1786–W1189 (2004) (0)
- Sa1281 Long Term Adherence to a Gluten Free Diet (2013) (0)
- Serum neutralizing antibodies affect toxin detection limits of cell-based assays. (2015) (0)
- Mo1114 The Liver in Celiac Disease and Effect of the Gluten Free Diet (2014) (0)
- Royal Academy of Medicine in Ireland Section of Medicine (1989) (0)
- S1312 Time Trends of Micronutrient Deficiencies in Newly Diagnosed Celiac Disease: A Story of Denominators (2020) (0)
- Reply to GASTRO-D-20-00033. (2020) (0)
- Mo1839 A Leaky Colonic Vascular Barrier Caused by Clostridium difficile Toxins A and B Contributes to the Pathogenesis of C. difficile Infection (2015) (0)
- Preservation of the Innate Immune Response to Clostridioides difficile Infection in Hospitalized Immunocompromised Patients (2023) (0)
- Saccharomyces Boulardii CNCM I-745 Lowers Fecal Cholic Acid Concentrations During Antibiotherapy in Healthy Volunteers: A New Potential Mechanism in the Protection Against Clostridium Difficile Infection (2017) (0)
- Su1182 STOOL INTERLEUKIN-1β AS A POTENTIAL DIAGNOSTIC BIOMARKER FOR CLOSTRIDIOIDES DIFFICILE INFECTION (2020) (0)
- 46 Pseudomembranous colitis and Clostridium difficile infection (0)
- Large intestine. (2012) (0)
- P-225 TLR9 Mediates Host Inflammatory Response in Clostridium difficile Infection (2013) (0)
- 348 Clostridium difficile Toxin a Harbors Bacterial DNA and Activates TLR9-Dependant Innate Immune Responses (2015) (0)
- Clinical Features and Survival in Refractory Celiac Disease: Preliminary Report from a Multinational Collaborative Study: ACG Governors Award for Excellence in Clinical Research: 1082 (2011) (0)
- Hitting the Jackpot: Achieving Diagnostic and Therapeutic Success in Gastroenterology 2016 ACG Annual Postgraduate Course (2016) (0)
- Predictors for Positive Findings on EGD, Colonoscopy, and Biopsy in Non-Responsive Celiac Disease (2017) (0)
- Inaugural national scientific medical meeting (1993) (0)
- Endogenous Serum IgG Antibodies to Toxin B Are Associated with Protection against Infection Recurrence. (2017) (0)
- T2050 Interleukin-8 Promoter Polymorphism and Risk of Clostridium difficile Infection (2009) (0)
- Celiac Crisis In Adults: A Case Series: 285 (2009) (0)
- rospective Derivation and Validation of a Clinical Prediction Rule for ecurrent Clostridium difficile Infection (0)
- 1004 Celiac Disease Model in Rag1-/- Mice Adoptively Transferred with Gliadin-Sensitized Effector/Memory T Cells, Challenged with Oral Gluten (2008) (0)
- Editorial introductions. (2020) (0)
- Mo1022 - Diagnostic Accuracy of Point of Care Tests for Diagnosing Celiac Disease: A Systematic Review and Meta-Analysis (2018) (0)
- Anepidemic ofpseudomembranous colitis: Importance ofperson topersonspread (1987) (0)
- Diseases Producing Malabsorption and Maldigestion (2019) (0)
- Nutritional Management of Celiac Disease (2018) (0)
- RELATIONSHIP BETWEEN QUANTITATIVE 13C BREATH TESTING AND QUANTITATIVE H. PYLORI CULTURE BY ENDOSCOPY FOR ITS USEFULNESS AS AN EARLY ASSAY OF ANTIBIOTIC EFFECT: 120 (2004) (0)
- Clostridium Difficile Toxin A-associated DNA Augments the Host Inflammatory Response: P-258 YI (2012) (0)
- Dynamics of 90-Day Mortality After In-hospital Clostridium difficile Infection and C.difficilenegative Controls: 155 (2017) (0)
- Sa1308 Is Celiac Disease Protective Against Non-Insulin Dependent Diabetes Mellitus? (2012) (0)
- Mo1988 – Use of Cladribine for Ulcerative Jejunitis in Celiac Disease: A Single-Center Experience in North America (2019) (0)
- Sa1327 Self-Administered Celiac Disease Testing: A Practical Approach in High Risk Individuals (2012) (0)
- Inter- and Intra-assay variation in the diagnostic performance of anti-tissue transglutaminase antibody assays in two populations (2020) (0)
- Rho proteins and P38 map kinase are required for IL-8 gene expression induced by Clostridium difficile toxin B in monocytes (2000) (0)
- 650 Role of Ethnicity and IL-8 Polymorphisms in Clostridium difficile Susceptibility (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ciaran Patrick Kelly?
Ciaran Patrick Kelly is affiliated with the following schools:
